Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Mary M. Gooley Hemophilia Center is a specialized non-profit healthcare provider located in Rochester, New York, dedicated to the treatment of hemophilia and other rare bleeding and clotting disorders. Founded in 1959, it was one of the first standalone hemophilia treatment centers in the United States and provides comprehensive care including diagnostic testing, pharmacy services, and physical therapy. The center operates as a federally recognized Hemophilia Treatment Center (HTC) and participates in clinical research trials to advance therapies for bleeding disorders. Its multidisciplinary team offers personalized treatment plans, education, and support services to patients and their families across the Finger Lakes region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mary M. Gooley Hemophilia Center.